Sherbrooke Park Advisers LLC Xencor Inc Transaction History
Sherbrooke Park Advisers LLC
- $436 Billion
- Q3 2024
Shares
1 transactions
Others Institutions Holding XNCR
# of Institutions
216Shares Held
71.5MCall Options Held
2.5KPut Options Held
7.9K-
Black Rock Inc. New York, NY11.1MShares$227 Million0.0% of portfolio
-
Primecap Management CO Pasadena, CA9.14MShares$187 Million0.14% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.6MShares$155 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA5.33MShares$109 Million4.65% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.93MShares$80.4 Million0.01% of portfolio
About Xencor Inc
- Ticker XNCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,698,100
- Market Cap $1.22B
- Description
- Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...